These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 28524730)

  • 1. Recent advances in genetic testing for familial hypercholesterolemia.
    Iacocca MA; Hegele RA
    Expert Rev Mol Diagn; 2017 Jul; 17(7):641-651. PubMed ID: 28524730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beyond the Usual Suspects: Expanding on Mutations and Detection for Familial Hypercholesterolemia.
    Ibrahim S; Defesche JC; Kastelein JJP
    Expert Rev Mol Diagn; 2021 Sep; 21(9):887-895. PubMed ID: 34263698
    [No Abstract]   [Full Text] [Related]  

  • 3. The Present and the Future of Genetic Testing in Familial Hypercholesterolemia: Opportunities and Caveats.
    Hooper AJ; Burnett JR; Bell DA; Watts GF
    Curr Atheroscler Rep; 2018 May; 20(6):31. PubMed ID: 29779130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polygenic Versus Monogenic Causes of Hypercholesterolemia Ascertained Clinically.
    Wang J; Dron JS; Ban MR; Robinson JF; McIntyre AD; Alazzam M; Zhao PJ; Dilliott AA; Cao H; Huff MW; Rhainds D; Low-Kam C; Dubé MP; Lettre G; Tardif JC; Hegele RA
    Arterioscler Thromb Vasc Biol; 2016 Dec; 36(12):2439-2445. PubMed ID: 27765764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next-generation-sequencing-based identification of familial hypercholesterolemia-related mutations in subjects with increased LDL-C levels in a latvian population.
    Radovica-Spalvina I; Latkovskis G; Silamikelis I; Fridmanis D; Elbere I; Ventins K; Ozola G; Erglis A; Klovins J
    BMC Med Genet; 2015 Sep; 16():86. PubMed ID: 26415676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Cost-effectiveness of Genetic Screening for Familial Hypercholesterolemia: a Systematic Review.
    Rosso A; Pitini E; D'Andrea E; Massimi A; De Vito C; Marzuillo C; Villari P
    Ann Ig; 2017; 29(5):464-480. PubMed ID: 28715059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of next-generation sequencing to detect
    Iacocca MA; Wang J; Dron JS; Robinson JF; McIntyre AD; Cao H; Hegele RA
    J Lipid Res; 2017 Nov; 58(11):2202-2209. PubMed ID: 28874442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular screening of familial hypercholesterolemia in Icelanders.
    Kellogg G; Thorsson B; Cai Y; Wisotzkey R; Pollock A; Akana M; Fox R; Jansen M; Gudmundsson EF; Patel B; Chang C; Jaremko M; Puig O; Gudnason V; Emilsson V
    Scand J Clin Lab Invest; 2020 Oct; 80(6):508-514. PubMed ID: 32706999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next generation sequencing to identify novel genetic variants causative of autosomal dominant familial hypercholesterolemia associated with increased risk of coronary heart disease.
    Al-Allaf FA; Athar M; Abduljaleel Z; Taher MM; Khan W; Ba-Hammam FA; Abalkhail H; Alashwal A
    Gene; 2015 Jul; 565(1):76-84. PubMed ID: 25839937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited-Variant Screening vs Comprehensive Genetic Testing for Familial Hypercholesterolemia Diagnosis.
    Sturm AC; Truty R; Callis TE; Aguilar S; Esplin ED; Garcia S; Haverfield EV; Morales A; Nussbaum RL; Rojahn S; Vatta M; Rader DJ
    JAMA Cardiol; 2021 Aug; 6(8):902-909. PubMed ID: 34037665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic analysis of variants related to familial hypercholesterolemia in families with premature myocardial infarction.
    Brænne I; Kleinecke M; Reiz B; Graf E; Strom T; Wieland T; Fischer M; Kessler T; Hengstenberg C; Meitinger T; Erdmann J; Schunkert H
    Eur J Hum Genet; 2016 Feb; 24(2):191-7. PubMed ID: 26036859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of clinical diagnostic criteria for familial hypercholesterolemia genetic testing in Poland.
    Mickiewicz A; Chmara M; Futema M; Fijalkowski M; Chlebus K; Galaska R; Bandurski T; Pajkowski M; Zuk M; Wasag B; Limon J; Rynkiewicz A; Gruchala M
    Atherosclerosis; 2016 Jun; 249():52-8. PubMed ID: 27062410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic testing for familial hypercholesterolemia-past, present, and future.
    Futema M; Taylor-Beadling A; Williams M; Humphries SE
    J Lipid Res; 2021; 62():100139. PubMed ID: 34666015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular diagnosis methods in familial hypercholesterolemia.
    Moldovan V; Banescu C; Dobreanu M
    Anatol J Cardiol; 2020 Feb; 23(3):120-127. PubMed ID: 32120369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Approaches in Detection and Treatment of Familial Hypercholesterolemia.
    Hartgers ML; Ray KK; Hovingh GK
    Curr Cardiol Rep; 2015 Dec; 17(12):109. PubMed ID: 26482752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimising the detection and management of familial hypercholesterolaemia: central role of primary care and its integration with specialist services.
    Vickery AW; Bell D; Garton-Smith J; Kirke AB; Pang J; Watts GF
    Heart Lung Circ; 2014 Dec; 23(12):1158-64. PubMed ID: 25130889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotype-guided diagnosis in familial hypercholesterolemia: clinical management and concerns.
    Hopkins PN; Lane SR
    Curr Opin Lipidol; 2017 Apr; 28(2):144-151. PubMed ID: 28157722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
    Goldberg AC; Hopkins PN; Toth PP; Ballantyne CM; Rader DJ; Robinson JG; Daniels SR; Gidding SS; de Ferranti SD; Ito MK; McGowan MP; Moriarty PM; Cromwell WC; Ross JL; Ziajka PE;
    J Clin Lipidol; 2011 Jun; 5(3 Suppl):S1-8. PubMed ID: 21600525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of familial hypercholesterolemia in Spain.
    Palacios L; Grandoso L; Cuevas N; Olano-Martín E; Martinez A; Tejedor D; Stef M
    Atherosclerosis; 2012 Mar; 221(1):137-42. PubMed ID: 22244043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.